Jan Stahlberg serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Jan Stahlberg has executed 1 insider transactions totaling $5.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 23, 2025 involved purchasing 1,542,857 shares valued at $5.4M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 23, 2025 | DMAC | $5.4M | Purchase | 1,542,857 | $3.50 | Discretionary |
Jan Stahlberg currently holds 6,764,465 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jan Stahlberg has been a net buyer of DMAC stock. They have purchased $5.4M and sold $0 worth of shares.
Jan Stahlberg's most recent insider trade was on Jul 23, 2025, when they purchased 1,542,857 shares at $3.50 per share.
Get notified when new Form 4 filings are submitted